Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang® vaccine in adolescents from low income families in Central Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue 3, 2006, Pages 251-256

  Oliveira, Michele Dias Da S ^a   Martins, Regina M B ^a   Matos, Marcos A ^a   Ferreira, Renata C ^a   Dias, Márcia A ^a   Carneiro, Megmar A S ^a   Junqueira, Ana Luiza N ^a   Teles, Sheila A ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Adolescents; Brazil; Hepatitis B; Vaccine

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BRAZIL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; MALE; POVERTY; PREVALENCE; REGRESSION ANALYSIS; RISK FACTOR;

ADOLESCENT; ADULT; BRAZIL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; POVERTY; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

HEPATITIS B VIRUS;

EID: 33745510083     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1079/BER2006420     Document Type: Article

References (38)

1. Assad S, Francis A 2000. Over decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine 18: 57-67.
2. Baldy JL, de Lima GZ, Morimoto HK, Reiche EM, Matsuo T, de Mattos ED, Sudan LC 2004. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination. Rev Inst Med Trop São Paulo 46: 103-107.
3. Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C, Nostro AL 2003. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine 21: 685-691.
4. Carroll ST, Riffenburgh RH, Roberts TA, Myhre EB 2002. Tattoos and body piercings as indicators of adolescents risk-taking behaviors. Pediatrics 109: 1021-1027.
5. Cisneros-Castolo M, Hernandez-Ruiz L, Ibarra-Robles IE, Fernandez-Garate RH, Escobedo-De La Pena J 2001. Prevalence of hepatitis B virus infection and related risk factors in a rural community of Mexico. Am J Trop Med Hyg 65: 759-763.
6. Clemens SAC, da Fonseca JC, Azevedo T, Cavalcanti A, Silveira TR, Castilho MC, Clemens R 2000. Soroprevalência para hepatite A e hepatite B em quatro centros no Brasil. Rev Soc Bras Med Trop 33: 1-10.
7. Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L 2000. Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996. Vaccine 18: 2345-2350.
8. EASL 2003. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 38: 533-540.
9. Gandolfo GM, Ferri GM, Conti L, Antenucci A, Marrone R, Frasca AM, Vitelli G 2003. Prevalence of infections by A, B, C and E viruses in two different socioeconomic groups of children from Santa Cruz, Bolívia. Med Clin (Barc) 120: 725-727.
10. Gawande AV, Vasudeo ND, Zodpey SP, Khandait DW 2000. Sexually transmitted infections in long distance truck drivers. J Commun Dis 32: 212-215.
11. Gaze R, Carvalho DM, Werneck GL 2002. Soroprevalência das infecções pelos vírus das hepatites A e B em Macaé, Rio de Janeiro, Brasil. Cad Saú Públ 18: 1251-1259.
12. Gibney L, Macaluso M, Kirk K, Hassan MS, Schwebke J, Vermund SH, Choudhury P 2001. Prevalence of infectious diseases in Bangladeshi women living adjacent to a truck stand: HIV/STD/hepatitis/genital tract infections. Sex Transm Infect 77: 344-350.
13. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, Maniatis A, Skoutelis A 2003. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol 18: 551-557.
14. Hayes MO, Harkness GA 2001. Body piercing as a risk factor for viral hepatitis: an integrative research review. Am J Infect Control 29: 271-274.
15. Hou J, Liu Z, Gu F 2005. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2: 50-57.
16. Ioshimoto LM, Rissato ML, Bonilha VS, Miyaki C, Raw II, Granovski N 1999. Safety and immunogenicity of hepatitis B vaccine Butang in adults. Rev Inst Med Trop São Paulo 41: 191-193.
17. Lauritsen JL, Swicegood CG 1997. The consistency of self-reported initiation of sexual activity. Fam Plann Perspect 29: 215-221.
18. Lawrence M, Goldstein MA 1995. Hepatitis B immunizations in adolescents. J Adolesc Health 17: 234-243.
19. Manjunath JV, Thappa DM, Jaisankar TJ 2002. Sexually transmitted diseases and sexual lifestyles of long-distance truck drivers: a clinico-epidemiologic study in South India. Int J STD AIDS 13: 612-617.
20. Martelli CM, Turchi M, Souto FJ, Saez-Alquezar A, Andrade AL, Zicker F 1999. Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity. Rev Panam Salud Pubica 6: 69-73.
21. Martins RM, Bensabath G, Arraes LC, Oliveira ML, Miguel JC, Barbosa GG, Camacho LA 2004. Multicenter study on the immonogenicity and safety of two recombinant vaccines against hepatitis B. Mem Inst Oswaldo Cruz 99: 865-871.
22. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ 2005. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 54: 1-31.
23. McQuillan GM, Townsend TR, Fields HA, Carroll M, Leahy M, Polk BF 1989. Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. Am J Med 87: 5S-10S.
24. Miranda AE, Gadelha AM, Szwarcwald CL 2005. Behavior patterns related to sexual practices and drug use among female adolescents in Vitória, Espírito Santo, Brazil. Cad Saú Públ 21: 207-216.
25. Passos AD, Gomes UA, Figueiredo JF, do Nascimento MM, de Oliveira JM, Gaspar AM, Yoshida CF 1993. Influence of migration on the prevalence of serologic hepatitis B markers in a rural community 2. Comparative analyses of various characteristics of the population studied. Rev Saú Públ 27: 36-42.
26. Porto SO, Cardoso DD, Queiroz DA, Rosa H, Andrade AL, Zicker F, Martelli CM 1994. Prevalence and risk factors for HBV infection among street youth in central Brazil. J Adolesc Health 15: 577-581.
27. Roberts TA, Ryan SA 2002. Tattooing and high-risk behavior in adolescents. Pediatrics 110: 1058-1063.
28. Salleras L, Dominguez A, Bruguera M, Cardenosa N, Batalla J, Carmona G, Navas E, Taberner JL 2005. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Vaccine 23: 2181-2184.
29. Schiff GM, Sherwood JR, Zeldis JB, Krause DS 1995. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. J Adolesc Health 16: 12-17.
30. Seid M, Simmes DR, Linton LS, Leah CE, Edwards CC, Peddecord KM 2001. Correlates of vaccination for hepatitis B among adolescents: results from a parent survey. Arch Pediatr Adolesc Med 155: 921-926.
31. Silveira TR, da Fonseca JC, Rivera L, Fay OH, Tapia R, Santos JI, Urdeneta E, Clemens SA 1999. Hepatitis B seroprevalence in Latim America. Panam Salud Publica 6: 378-383.
32. Souto FJD 1999. Distribuição da hepatite B no Brasil: atualização do mapa epidemiológico e proposiçõ es para o seu controle. GED 18: 143-150.
33. Souto FJ, Fontes CJ, Gaspar AMC 1998. Outbreak of hepatitis B virus in recent arrivals to Brazilian Amazon. J Med Virol 56: 4-9.
34. Turchi MD, Martelli CM, Ferraz ML, Silva AE, Cardoso DD, Martelli P, Oliveira LJ 1997. Immunogenicity of low-dose intramuscular and intradermal vaccination with recombinant hepatitis B vaccine. Rev Inst Med Trop São Paulo 39: 15-19.
35. Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S 2000. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 19: 1026-1037.
36. Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, Hall A 2002. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ 325: 569.
37. WHO-World Health Organization 2003. Hepatitis B vaccine: Immunization, Vaccines and Biologicals, Geneve.
38. Zuckerman J, Langer B 2005. Hepatitis B vaccination in a school age population: a feasibility study. J Med Virol 76: 47-54.